Mechanisms and Implications of HER2 Resistance - An Interview with Dr. William Gradishar PracticeUpdate 5:15 3 years ago 47 Скачать Далее
Dr. William Gradishar on the Importance of Enriching Clinical Trials OncLive 0:47 11 years ago 68 Скачать Далее
Dr. William Gradishar on Updates in NCCN Breast Cancer Guidelines OncLive 2:09 8 years ago 587 Скачать Далее
#CABC#Prof. William J. Gradishar: Individualized Treament Scheme for Breast Cancer ASVIDE 7:50 7 years ago 31 Скачать Далее
Dr. William Gradishar Discusses 10 Years of Adjuvant Tamoxifen OncLive 1:22 11 years ago 330 Скачать Далее
Dr. William Gradishar Discusses the Eribulin and Capecitabine 301 Study OncLive 1:38 11 years ago 349 Скачать Далее
Mechanisms and Implications of HER2 Resistance - An Interview with Dr. William Gradishar.mp4 PracticeUpdate 5:21 7 years ago 71 Скачать Далее
Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Br... Research To Practice 2:35:50 1 month ago 38 Скачать Далее
Dr. William Gradishar on the Standard Duration of Tamoxifen Targeted Oncology 2:25 11 years ago 193 Скачать Далее
HER2 Biosimilars in Clinical Practice - An Interview with Dr. William Gradishar PracticeUpdate 2:55 3 years ago 14 Скачать Далее
Asvide: Professor William J. Gradishar: individualized treatment scheme for breast cancer ASVIDE 7:50 4 years ago 29 Скачать Далее
HER2 Biosimilars in Clinical Practice - An Interview with Dr. William Gradishar.mp4 PracticeUpdate 3:01 7 years ago 44 Скачать Далее
Dr. Gradishar on Using Genetic Testing to Identify Actionable Results in Breast Cancer OncLive 2:04 6 years ago 104 Скачать Далее
SABCS Snippets: After ASCO 2024 San Antonio Breast Cancer Symposium 20:17 1 month ago 252 Скачать Далее
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Bagegni & Dr. Gradishar Total Health | Oncology 55:48 3 years ago 813 Скачать Далее
Dr. Gradishar Comments on the Treatment of Early Stage Breast Cancer With Endocrine Therapy OncLive 2:57 10 years ago 416 Скачать Далее
